 | Up a level |
Ahn, Myung-Ju and Mendoza, Marvin Jonne L. and Pavlakis, Nick and Kato, Terufumi and Soo, Ross A. and Kim, Dong-Wan and Liam, Chong Kin and Hsia, Te-Chun and Lee, Chee Khoon and Reungwetwattana, Thanyanan and Geater, Sarayut and Chan, Oscar Siu Hong and Prasongsook, Naiyarat and Solomon, Benjamin J. and Nguyen, Thi Thai Hoa and Kozuki, Toshiyuki and Yang, James Chih-Hsin and Wu, Yi-Long and Kam, Tony Shu and Tan, Daniel Shao-Weng and Yatabe, Yasushi (2022) Asian Thoracic Oncology Research Group (ATORG) expert consensus statement on MET alterations in NSCLC: Diagnostic and therapeutic considerations. CLINICAL LUNG CANCER, 23 (8). pp. 670-685. ISSN 1938-0690, DOI https://doi.org/10.1016/j.cllc.2022.07.012.
Ang, Yvonne L. E. and Ho, Gwo Fuang and Soo, Ross A. and Sundar, Raghav and Tan, Sing Huang and Yong, Wei Peng and Ow, Samuel G. W. and Lim, Joline S. J. and Chong, Wan Qin and Soe, Phyu Pyar and Tai, Choo and Wang, Lingzhi and Goh, Boon Cher and Lee, Soo-Chin (2020) A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. BMC Cancer, 20 (1). ISSN 1471-2407, DOI https://doi.org/10.1186/s12885-020-07616-4.
